Imetelstat (Rytelo)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 04:52, 23 November 2014 by Jwarner (talk | contribs) (Jwarner moved page Imetelstat to Imetelstat (GRN163L))
Jump to navigation Jump to search

Mechanism of action

A lipid-conjugated oligonucleotide inhibitor of human telomerase. Link to company website

Preliminary data

Myelofibrosis

  1. Abstract: Kebede Begna, Rebecca R. Laborde, Mrinal M Patnaik, Terra L Lasho, Darci Zblewski, Christy Finke, Lauren Schimek, Betsy R. LaPlant, Curtis A. Hanson, Monic J. Stuart, Animesh Pardanani. Imetelstat, a Telomerase Inhibitor, Induces Morphologic and Molecular Remissions In Myelofibrosis and Reversal Of Bone Marrow Fibrosis. Blood Nov 2013,122(21)662 link to original abstract
Retrieved from "https://hemonc.org/w/index.php?title=Imetelstat_(Rytelo)&oldid=5918"